View in EDS HTML Full Text PDF Full Text

Atogepant for the Preventive Treatment of Migraine in Japanese Participants: A Phase 3, Open-Label, 52-Week Extension Study.

Saved in:
Bibliographic Details
Title: Atogepant for the Preventive Treatment of Migraine in Japanese Participants: A Phase 3, Open-Label, 52-Week Extension Study.
Authors: Matsumori, Yasuhiko1 (AUTHOR), Nagy, Krisztian2 (AUTHOR) krisztian.nagy@abbvie.com, Takahashi, Akihiro3 (AUTHOR), Tanaka, Shigeya4 (AUTHOR), Takeshima, Takao5 (AUTHOR), Forero, Giovanna2 (AUTHOR), Bao, Jia2 (AUTHOR), Guo, Hua2 (AUTHOR), Ahmadyar, Gina2 (AUTHOR), de Abreu Ferreira, Rosa2 (AUTHOR), Yamamoto, Toshimasa6 (AUTHOR)
Source: Neurology & Therapy. Jun2026, Vol. 15 Issue 3, p1137-1154. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938253
DOI:10.1007/s40120-026-00905-3